Skip to search formSkip to main contentSkip to account menu

Fibrinogen 55.5 MG / Thrombin 20.3 UNT Medicated Patch [TachoSil]

Known as: HUMAN THROMBIN 5.5 mg / FIBRINOGEN HUMAN 2.0 [USP'U] TOPICAL PATCH [TachoSil], TachoSil (fibrinogen 55.5 MG / thrombin 20.3 UNT) Medicated Patch, TachoSil 1.2 inch x 1 inch Medicated Patch 
National Institutes of Health

Related topics

Related topics

10 relations
Albumin Human, USPArginine hydrochlorideEQUUS CABALLUS COLLAGENMedicated Patch

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Efficacy of a collagen-fibrin sealant patch (TachoSil®) as adjuvant treatment in the inguinofemoral lymphadenectomy for vulvar cancer: a double-blind randomized-controlled trial
PurposeTo evaluate the effect of a collagen-fibrin sealant patch (TachoSil®) in preventing postoperative complications after… 
Review
2019
Review
2019
Evolution of the surgical sealing patch TachoSil® in Peyronie’s disease reconstructive surgery: technique and contemporary literature review
PurposeThe aim of this study is to review the current literature that reports outcomes of Peyronie’s disease (PD) reconstructive… 
2018
2018
A randomized, controlled trial of Veriset™ hemostatic patch in halting cardiovascular bleeding
Background Obtaining hemostasis during cardiovascular procedures can be a challenge, particularly around areas with a complex… 
2016
2016
Fibrinogen-thrombin collagen patch reinforcement of high-risk colonic anastomoses in rats
AIM To evaluate the effectiveness of human fibrinogen-thrombin collagen patch (TachoSil®) in the reinforcement of high-risk colon… 
2016
2016
Use of TachoSil® to Prevent Symptomatic Lymphocele after an Aggressive Tumor Debulking with Lymphadenectomy for Advanced Stage Ovarian Cancer. A Pilot Study
Objective: To describe the incidence of symptomatic lymphocele (SLC) after an aggressive tumor debulking surgery and… 
2015
2015
Experiences with TachoSil® in microneurosurgery
BackgroundWe analyze our experience of using TachoSil® (Takeda Austria GmbH: Linz, Austria) in microneurosurgical procedures as a… 
2013
2013
Efficacy and safety of human fibrinogen-thrombin patch (TachoSil®) in the treatment of postoperative air leakage in patients submitted to redo surgery for lung malignancies: a randomized trial.
OBJECTIVES Previous studies of the human fibrinogen-thrombin patch TachoSil® for air leak management in thoracic surgery have… 
2012
2012
Use of Tachosil® in bariatric surgery: preliminary experience in control of bleeding after sleeve gastrectomy.
AIM Laparoscopic sleeve gastrectomy (LSG) is one of the most common procedures of bariatric surgery. Nevertheless complications… 
2011
2011
[Enteric anastomosis and Tachosil®].
AIM Anastomotic leakage is a common complication of colorectal surgery. To date, no clinical study exists showing a significant… 
2009
2009
Efficiency of TachoSil® to prevent postsurgical adhesion development on laparoscopic rat model
The aim of this study was to evaluate the effectiveness of a fibrinogen and thrombin-coated hemostatic sponge (TachoSil®) in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)